日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lung Microphysiological System Validates Novel Cell Therapy for Acute Respiratory Distress Syndrome.

肺微生理系统验证了治疗急性呼吸窘迫综合征的新型细胞疗法。

Kim Bokyong, Kim So-Hui, Kim Jieun, Eo Eun-Young, Kim Hyung-Jun, Lee Jae Ho, Lee Choon-Taek, Kong Taeho, Seo Su Kyoung, Lee Seunghee, Park Jeongbin, Cho Young-Jae

Amelioration of Particulate Matter-Induced Oxidative Stress by a Bioactive Hizikia fusiformis Extract: A Functional Biomaterial for Cosmeceutical Applications.

生物活性羊栖菜提取物对颗粒物引起的氧化应激的改善作用:一种用于化妆品应用的功能性生物材料

Ahn Jeong Won, Kim Hyun Soo, Kim So Hui, Yang Hye Soo, Damodar Kongara, Yoo Yeong-Min, Hong Jin Tae, Joo Seong Soo

The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine

硫酸锌在增强口蹄疫疫苗的细胞和体液免疫反应中的作用

Mi-Kyeong Ko ,Hyeong Won Kim ,So Hui Park ,Jong-Hyeon Park ,Su-Mi Kim ,Min Ja Lee

miR-4487 Enhances Gefitinib-Mediated Ubiquitination and Autophagic Degradation of EGFR in Non-Small Cell Lung Cancer Cells by Targeting USP37

miR-4487 通过靶向 USP37 增强吉非替尼介导的非小细胞肺癌细胞中 EGFR 的泛素化和自噬降解

Mi Seong Kim, So Hui Kim, Sei Hoon Yang, Min Seuk Kim

Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non-Small Cell Lung Cancer Cells

阿法替尼介导ORAI1、STIM1和SERCA2的自噬降解,从而抑制非小细胞肺癌细胞的增殖。

Kim, Mi Seong; Kim, So Hui; Yang, Sei-Hoon; Kim, Min Seuk

Restricting extracellular Ca2+ on gefitinib-resistant non-small cell lung cancer cells reverses altered epidermal growth factor-mediated Ca2+ response, which consequently enhances gefitinib sensitivity

限制对吉非替尼有耐药性的非小细胞肺癌细胞的细胞外 Ca2+ 可逆转改变的表皮生长因子介导的 Ca2+ 反应,从而增强吉非替尼的敏感性

Mi Seong Kim, So Hui Kim, Sei Hoon Yang, Min Seuk Kim